Australia markets open in 6 hours 10 minutes

Integra LifeSciences Holdings Corporation (IART)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
43.62+0.41 (+0.95%)
As of 01:49PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 3.64B
Enterprise value 4.91B
Trailing P/E 22.13
Forward P/E 12.18
PEG ratio (5-yr expected) 1.01
Price/sales (ttm)2.36
Price/book (mrq)2.19
Enterprise value/revenue 3.13
Enterprise value/EBITDA 13.56

Trading information

Stock price history

Beta (5Y monthly) 1.12
52-week change 3-36.90%
S&P500 52-week change 3-13.66%
52-week high 374.98
52-week low 341.87
50-day moving average 351.05
200-day moving average 359.66

Share statistics

Avg vol (3-month) 3485.11k
Avg vol (10-day) 3531.49k
Shares outstanding 583.5M
Implied shares outstanding 6N/A
Float 872.49M
% held by insiders 113.01%
% held by institutions 190.56%
Shares short (30 Aug 2022) 43.95M
Short ratio (30 Aug 2022) 49.21
Short % of float (30 Aug 2022) 46.30%
Short % of shares outstanding (30 Aug 2022) 44.73%
Shares short (prior month 28 July 2022) 44.25M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 303 Jan 2017

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 June 2022


Profit margin 10.61%
Operating margin (ttm)18.13%

Management effectiveness

Return on assets (ttm)4.76%
Return on equity (ttm)10.28%

Income statement

Revenue (ttm)1.57B
Revenue per share (ttm)18.63
Quarterly revenue growth (yoy)2.00%
Gross profit (ttm)976.97M
EBITDA 404.32M
Net income avi to common (ttm)166.3M
Diluted EPS (ttm)1.98
Quarterly earnings growth (yoy)27.70%

Balance sheet

Total cash (mrq)451.52M
Total cash per share (mrq)5.41
Total debt (mrq)1.72B
Total debt/equity (mrq)103.41
Current ratio (mrq)3.85
Book value per share (mrq)19.89

Cash flow statement

Operating cash flow (ttm)262.88M
Levered free cash flow (ttm)185.93M